This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
|Name of User Fee||Fee Type||Fee-setting Authority||Reason for Planned Introduction of or Amendment to Fee||Effective Date of Planned Change||Consultation and Review Process Planned|
|Authority to Sell Drugs Fees - AMENDED||Regulatory Service (R)||Financial Administration Act (FAA)||Existing fees have not been revised since originally implemented in 1995-2000, while the cost of doing business and the number and scope of regulatory activities has increased.
Updated fees will provide stable and sustainable resourcing of these regulatory programs. It will allow Health Canada to meets its internationally-recognized performance standards.
|2011-2012||Having completed stakeholder consultations and two Independent Advisory Panels (to address complaints under the User Fees Act), the Parliamentary tabling of a User Fee Proposal to update Human Drug and Medical Device Fees took place in April 2010. It was officially approved by Parliament in May 2010, and the publication of revised fee
regulations in the Canada Gazette is anticipated to take place in late 2010.
Additional information on consultation activities is available on the HPFB Cost Recovery Initiative website: www.healthcanada.gc.ca/ hpfb_costrecovery
|Drug Establishment Licensing Fees - AMENDED||R||FAA|
|Drug Submission Evaluation Fees - AMENDED||R||FAA|
|Medical Device License Application Fees - AMENDED||R||FAA|
|Authority to Sell Medical Device Fees - AMENDED||R||FAA|
|Medical Device Establishment Licensing Fees - AMENDED||R||FAA|